These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 229517)
21. Captopril inhibits both dopaminergic and cholinergic neurotransmission in the central nervous system. Tsuda K; Tsuda S; Nishio I; Masuyama Y; Goldstein M Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):904-7. PubMed ID: 9807661 [TBL] [Abstract][Full Text] [Related]
22. GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease. Bartholini G; Scatton B; Zivkovic B; Lloyd KG Adv Neurol; 1987; 45():79-83. PubMed ID: 3030072 [TBL] [Abstract][Full Text] [Related]
23. Recent finding on dopaminergic transmission in the basal ganglia. Glowinski J Adv Neurol; 1990; 53():67-73. PubMed ID: 2173377 [No Abstract] [Full Text] [Related]
24. [The effect of the dopamine neuronal reuptake inhibitor GBR 12909 on the dopaminergic neurotransmission parameters in the rat striatum in vivo]. Budygin EA; Kilpatrick M; Gaĭnetdinov RR; Raevskiĭ KS; Wightman RM Eksp Klin Farmakol; 1999; 62(5):3-6. PubMed ID: 10572741 [TBL] [Abstract][Full Text] [Related]
25. [Role of dopamine receptors in regulating glutamatergic synaptic transmission in the rat neostriatum]. Godukhin OV; Zharikova AD; Zakharova LI Fiziol Zh SSSR Im I M Sechenova; 1981 Mar; 67(3):384-9. PubMed ID: 6113995 [No Abstract] [Full Text] [Related]
26. Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum. Zackheim J; Abercrombie ED Neuroscience; 2005; 131(2):423-36. PubMed ID: 15708484 [TBL] [Abstract][Full Text] [Related]
27. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [TBL] [Abstract][Full Text] [Related]
28. Studies of muscarinic neurotransmission with antimuscarinic toxins. Potter LT; Flynn DD; Liang JS; McCollum MH Prog Brain Res; 2004; 145():121-8. PubMed ID: 14650911 [TBL] [Abstract][Full Text] [Related]
29. Chronic modification of dopaminergic transmission and its effects on binding characteristics of dopamine transporter ligand 3H-GBR 12783 in the striatum. Valchár M; Bonnet JJ; Costentin J Act Nerv Super (Praha); 1989 Dec; 31(4):273-4. PubMed ID: 2561622 [No Abstract] [Full Text] [Related]
30. Cholinergic neuropil of the striatum observes striosomal boundaries. Graybiel AM; Baughman RW; Eckenstein F Nature; 1986 Oct 16-22; 323(6089):625-7. PubMed ID: 3773990 [TBL] [Abstract][Full Text] [Related]
31. Sensitivity of cholinergic neurons to GABAergic and serotoninergic drugs in the rat striatum. Javoy-Agid F Appl Neurophysiol; 1979; 42(1-2):75-7. PubMed ID: 453807 [No Abstract] [Full Text] [Related]
32. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Di Chiara G; Morelli M; Consolo S Trends Neurosci; 1994 Jun; 17(6):228-33. PubMed ID: 7521083 [TBL] [Abstract][Full Text] [Related]
33. Dopamine receptor alterations with aging in mouse and rat corpus striatum. Marquis JK; Lippa AS; Pelham RW Biochem Pharmacol; 1981 Jul; 30(13):1876-8. PubMed ID: 6268112 [No Abstract] [Full Text] [Related]
34. Effect of neuropeptides on classic types of neurotransmission in the rat central nervous system. Kito S; Miyoshi R Adv Exp Med Biol; 1991; 287():1-11. PubMed ID: 1684694 [No Abstract] [Full Text] [Related]
35. Regulation of the activity of striatal cholinergic neurons by dopamine. Stoof JC; Drukarch B; de Boer P; Westerink BH; Groenewegen HJ Neuroscience; 1992; 47(4):755-70. PubMed ID: 1579210 [No Abstract] [Full Text] [Related]
36. Altered striatal dopaminergic and cholinergic reciprocal inhibitory control and motor behavioral decrements in senescence. Joseph JA; Roth GS Ann N Y Acad Sci; 1988; 521():110-22. PubMed ID: 3288037 [No Abstract] [Full Text] [Related]
37. An action potential initiation mechanism in distal axons for the control of dopamine release. Liu C; Cai X; Ritzau-Jost A; Kramer PF; Li Y; Khaliq ZM; Hallermann S; Kaeser PS Science; 2022 Mar; 375(6587):1378-1385. PubMed ID: 35324301 [TBL] [Abstract][Full Text] [Related]
38. The cholinergic system and neostriatal memory functions. Havekes R; Abel T; Van der Zee EA Behav Brain Res; 2011 Aug; 221(2):412-23. PubMed ID: 21129408 [TBL] [Abstract][Full Text] [Related]
39. Prenatal psychotropic drug exposure and the development of central dopaminergic and cholinergic neurotransmitter systems. Friedhoff AJ; Miller JC Monogr Neural Sci; 1983; 9():91-8. PubMed ID: 6310384 [No Abstract] [Full Text] [Related]
40. Acetylcholine-dopamine balance in striatum: is it still a target for antiparkinsonian therapy? Calabresi P; Stefani A; Mercuri NB; Bernardi G EXS; 1989; 57():315-21. PubMed ID: 2533102 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]